Gene · 60489
Papers3,812
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,812
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DisoFLAG: accurate prediction of protein intrinsic disorder and its functions using graph-based interaction protein language model. | BMC Biol | 2024 | 38166858 | PubTator, text mining | PubMed |
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance. | J Antimicrob Chemother | 2024 | 38153241 | PubTator, text mining | PubMed |
| Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | Biophys J | 2024 | 38115583 | PubTator, text mining | PubMed |
| HIV-1 Vif protein sequence variations in South African people living with HIV and their influence on Vif-APOBEC3G interaction. | Eur J Clin Microbiol Infect Dis | 2024 | 38072879 | PubTator, text mining | PubMed |
| The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. | Nat Genet | 2024 | 38049664 | PubTator, text mining | PubMed |
| Establishment of cell culture model and humanized mouse model of chronic hepatitis B virus infection. | Microbiol Spectr | 2024 | 38018998 | PubTator, text mining | PubMed |
| Improvement of C-to-U RNA editing using an artificial MS2-APOBEC system. | Biotechnol J | 2024 | 38010373 | PubTator, text mining | PubMed |
| SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks". | Cell Mol Immunol | 2024 | 37985854 | PubTator, text mining | PubMed |
| AAACH is a conserved motif in a cis-acting replication element that is artificially inserted into Senecavirus A genome. | Virus Res | 2024 | 37952688 | PubTator, text mining | PubMed |
| REDH: A database of RNA editome in hematopoietic differentiation and malignancy. | Chin Med J (Engl) | 2024 | 37386732 | PubTator, text mining | PubMed |
| Advances in anti-EV-A71 drug development research. | J Adv Res | 2024 | 37001813 | PubTator, text mining | PubMed |
| The APOBEC3G gene rs2294367(C>G) variant is associated with HIV-1 infection in Moroccan subjects. | Acta Trop | 2023 | 39492490 | PubTator, text mining | PubMed |
| The Repurposing of Cellular Proteins during Enterovirus A71 Infection. | Viruses | 2023 | 38257775 | PubTator, text mining | PubMed |
| Recent advancements in targeted protein knockdown technologies-emerging paradigms for targeted therapy. | Explor Target Antitumor Ther | 2023 | 38213543 | PubTator, text mining | PubMed |
| Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection. | Int J Mol Sci | 2023 | 38203551 | PubTator, text mining | PubMed |
| Novel Approaches to Inhibition of HBsAg Expression from cccDNA and Chromosomal Integrants: A Review. | J Clin Transl Hepatol | 2023 | 38161502 | PubTator, text mining | PubMed |
| Cellular proteins as potential targets for antiretroviral therapy. | Vopr Virusol | 2023 | 38156565 | PubTator, text mining | PubMed |
| Involvement of a Rarely Used Splicing SD2b Site in the Regulation of HIV-1 vif mRNA Production as Revealed by a Growth-Adaptive Mutation. | Viruses | 2023 | 38140666 | PubTator, text mining | PubMed |
| Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA. | Viruses | 2023 | 38140556 | PubTator, text mining | PubMed |
| Regulatory variants of APOBEC3 genes potentially associate with COVID-19 severity in populations with African ancestry. | Sci Rep | 2023 | 38105291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60489/papers?page=7